Skip to content

Radial Shock Waves for Functional Disability in Stroke

Effect of Radial Shock Waves for the Treatment of Upper Limb Functional Disability in Stroke Sequelae

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02924168
Enrollment
22
Registered
2016-10-05
Start date
2013-09-30
Completion date
2018-02-28
Last updated
2018-06-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ischemic Stroke

Brief summary

This is a double blind randomized clinical trial to evaluate the effect of radial shock waves on functional recovery of the upper limb of patients with sequelae of ischemic strokes in the territory of the middle cerebral artery. A total of 20 patients will be enrolled and will undergo motor, functional and cortical excitability evaluations before and after four weekly sessions of radial shockwaves. 5,000 pulses with a frequency of 15 Hz and 3.5 to 4 bar of air pressure will be applied to the active group, resulting in an energy flux density (EFD) of approximately 0.07 mJ/mm2. The sham group will receive identical treatment, except for the fact that no energy flux will be applied.

Interventions

DEVICEActive Radial Shockwave

Four weekly sessions of active radial shockwave treatment.

DEVICESham Radial Shockwave

Four weekly sessions of sham radial shockwave treatment.

Sponsors

Marta Imamura
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Clinical and radiological diagnosis: Magnetic Resonance Imaging (MRI) or Computed Tomography (CT) scan indicating Stroke in the territory of the middle cerebral artery; * 6 to 24 months after stroke date; * Stability observed in clinical medical evaluation * Granting of written informed consent to participate in the study

Exclusion criteria

* Individuals with a score lower than 24 on the Mini-mental test; * Previously documented strokes * Pregnancy * Patients treated with botulinum toxin, phenol, alcohol or previous surgeries six months before entering the study * Bone diseases, pre-existing joint damage, and deformities affecting the patient in a way to interfere with implementation of the proposed therapy * Psycho-affective disorder that prevents adherence * Joint pain that occurs within the movement range of therapies

Design outcomes

Primary

MeasureTime frameDescription
Fugl-Meyer Assessment (FMA)Change from baseline to 8 weeksMean change in Fugl Meyer Assessment score after four sessions of Radial Shockwave Therapy (RSWT) as compared to baseline.

Secondary

MeasureTime frameDescription
Visual Analogue Scale (VAS)Baseline, one and two monthsMultiple changes in VAS
Esthesiometry - Von Frey ScaleBaseline, one and two monthsMultiple changes in Von Frey Scale
Upper Limb Modified Ashworth Scale (MAS)Baseline, one week, two weeks, three weeks, four weeks and two monthsMultiple changes in MAS
Fugl-Meyer AssessmentBaseline and two monthsChanges in Fugl-Meyer Assessment compared to baseline
Medical Research Council scale (MRC)Baseline, one and two monthsMultiple changes in MRC scale
Hand gripBaseline, one and two monthsMultiple changes in Hand grip
Jebsen-Taylor Hand Function Test (JTHFT)Baseline, one and two monthsMultiple changes in JTHFT
Purdue Pegboard Test (PPBT)Baseline, one and two monthsMultiple changes in PPBT
Robotic kinematic evaluation (RKE)Baseline, one and two monthsMultiple changes in RKE
Corticospinal excitability measures with transcranial magnetic stimulation (TMS)Baseline, one and two monthsMultiple changes in Corticospinal excitability
Pinch strength testingBaseline, one and two monthsPinch strength testing
Change in fine motor function measured with Finger Tapping (FT)Baseline, one and two monthsMultiple changes in FT

Other

MeasureTime frameDescription
Adverse Events (AE)Weekly for two monthsAccountability of occurences of Adverse Events

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026